Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype

World Journal of Gastroenterology

Volumn 20, Issue 10, 2014, Pages 2482-2491

  Ghoshal, Uday C ^a   Srivastava, Deepakshi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Dysbiosis; Functional bowel disease; Glucose hydrogen breath test; Gut flora; Lactulose hydrogen breath test

Indexed keywords

ANTIBIOTIC AGENT; BILE SALT; NEOMYCIN; PROBIOTIC AGENT; RIFAXIMIN; SHORT CHAIN FATTY ACID; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ARTICLE; BACILLUS SUBTILIS; BACTERIAL METABOLISM; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; BIFIDOBACTERIUM; BILE ACID BREATH TEST; BLOATING; BREATH ANALYSIS; COLON MOTILITY; CONTROLLED CLINICAL TRIAL (TOPIC); DIARRHEA; DYSBIOSIS; ENTEROCOCCUS FAECIUM; FLATULENCE; GASTRIC SUCTION; GLUCOSE HYDROGEN BREATH TEST; HUMAN; HYDROGEN BREATH TEST; INTESTINE BIOPSY; INTESTINE DISTENSION; INTESTINE FUNCTION; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LACTULOSE BREATH TEST; META ANALYSIS (TOPIC); NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SMALL INTESTINE; URINARY URGENCY; ANIMAL; BACTERIA; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; HOST PARASITE INTERACTION; IRRITABLE BOWEL SYNDROME; METABOLISM; MICROBIOLOGY; PHENOTYPE; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BREATH TESTS; FERMENTATION; HOST-PARASITE INTERACTIONS; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROBIOTICS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84896842964     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i10.2482     Document Type: Article

References (95)

1. Ballou SK, Keefer L. Multicultural considerations in the diagnosis and management of irritable bowel syndrome: a selective summary. Eur J Gastroenterol Hepatol 2013; 25: 1127-1133 [PMID: 23778308 DOI: 10.1097/MEG.0b013e3283632bf2]
2. Gonzales Gamarra RG, Ruiz Sánchez JG, León Jiménez F, Cubas Benavides F, Díaz Vélez C. [Prevalence of irritable bowel syndrome in the adult population of the city of Chiclayo in 2011]. Rev Gastroenterol Peru 2012; 32: 381-386 [PMID: 23307088]
3. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol 2009; 24: 1601-1607 [PMID: 19788601 DOI: 10.1111/j.1440-1746.2009.05984.x]
4. Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤ 50 years of age. Scand J Gastroenterol 2013; 48: 523-529 [PMID: 23506174 DOI: 10.3109/00365521.2013.77 5328]
5. Ibrahim NK, Battarjee WF, Almehmadi SA. Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah. Libyan J Med 2013; 8: 21287 [PMID: 24054184 DOI: 10.3402/ ljm.v8i0.21287]
6. Lee YY, Waid A, Tan HJ, Chua AS, Whitehead WE. Rome III survey of irritable bowel syndrome among ethnic Malays. World J Gastroenterol 2012; 18: 6475-6480; discussion p. 6479 [PMID: 23197894 DOI: 10.3748/wjg.v18.i44.6475]
7. Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, Banka NH, Bose K, Bohidar NP, Chakravartty K, Shekhar NC, Desai N, Dutta U, Das G, Dutta S, Dixit VK, Goswami BD, Jain RK, Jain S, Jayanthi V, Kochhar R, Kumar A, Makharia G, Mukewar SV, Mohan Prasad VG, Mohanty A, Mohan AT, Sathyaprakash BS, Prabhakar B, Philip M, Veerraju EP, Ray G, Rai RR, Seth AK, Sachdeva A, Singh SP, Sood A, Thomas V, Tiwari S, Tandan M, Upadhyay R, Vij JC. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol 2008; 27: 22-28 [PMID: 18541934]
8. Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-2990 [PMID: 20572300]
9. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006; 4: 11-20 [PMID: 16431299]
10. Bouhnik Y, Alain S, Attar A, Flourié B, Raskine L, Sanson-Le Pors MJ, Rambaud JC. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94: 1327-1331 [PMID: 10235214]
11. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y) 2007; 3: 112-122 [PMID: 21960820]
12. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-808 [PMID: 17148502]
13. Ghoshal U, Ghoshal UC, Ranjan P, Naik SR, Ayyagari A. Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol 2003; 3: 9 [PMID: 12769832]
14. Carrara M, Desideri S, Azzurro M, Bulighin GM, Di Piramo D, Lomonaco L, Adamo S. Small intestine bacterial overgrowth in patients with irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2008; 12: 197-202 [PMID: 18700692]
15. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10 [PMID: 16567886]
16. Ghoshal UC, Kumar S, Mehrotra M, Lakshmi C, Misra A. Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea. J Neurogastroenterol Motil 2010; 16: 40-46 [PMID: 20535325 DOI: 10.5056/jnm.2010.16.1.40]
17. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-3506 [PMID: 11151884]
18. Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol 2011; 26 Suppl 3: 135-138 [PMID: 21443727 DOI: 10.1111/j.1440-1746.2011.06654. x]
19. Park H. The role of small intestinal bacterial overgrowth in the pathophysiology of irritable bowel syndrome. J Neurogastroenterol Motil 2010; 16: 3-4 [PMID: 20535319 DOI: 10.5056/ jnm.2010.16.1.3]
20. Ghoshal UC, Shukla R, Ghoshal U, Gwee KA, Ng SC, Quigley EM. The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam 2012; 2012: 151085 [PMID: 22577594 DOI: 10.1155/2012/151085]
21. Brown AC. Ulcerative colitis, Crohn's disease and irritable bowel syndrome patients need fecal transplant research and treatment. J Crohns Colitis 2014; 8: 179 [PMID: 24119331 DOI: 10.1016/j.crohns.2013.09.011]
22. Sampath K, Levy LC, Gardner TB. Fecal transplantation: beyond the aesthetic. Gastroenterology 2013; 145: 1151-1153 [PMID: 24055638 DOI: 10.1053/j.gastro.2013.09.015]
23. Grace E, Shaw C, Whelan K, Andreyev HJ. Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013; 38: 674-688 [PMID: 23957651 DOI: 10.1111/apt.12456]
24. Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan. Saudi J Gastroenterol 2011; 17: 371-375 [PMID: 22064333 DOI: 10.4103/1319-3767.87176]
25. Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1189-1205 [PMID: 20594245 DOI: 10.1111/j.1440-1746.2010.06353.x]
26. Lacy BE, Gabbard SL, Crowell MD. Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air? Gastroenterol Hepatol (N Y) 2011; 7: 729-739 [PMID: 22298969]
27. Harder H, Serra J, Azpiroz F, Passos MC, Aguadé S, Malagelada JR. Intestinal gas distribution determines abdominal symptoms. Gut 2003; 52: 1708-1713 [PMID: 14633947]
28. Kumar S, Misra A, Ghoshal UC. Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil 2010; 16: 299-305 [PMID: 20680169 DOI: 10.5056/jnm.2010.16.3.299]
29. Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice--an evidence-based international guide. Aliment Pharmacol Ther 2013; 38: 864-886 [PMID: 23981066 DOI: 10.1111/apt.12460]
30. Attar A, Flourié B, Rambaud JC, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999; 117: 794-797 [PMID: 10500060 DOI: 10.1016/S0016-5085(99)70336-7]
31. Marcelino RT, Fagundes-Neto U. [Hydrogen test (H2) in the air expired for the diagnosis of small bowel bacterial overgrowth]. Arq Gastroenterol 1995; 32: 191-198 [PMID: 8734856]
32. Santavirta J. Lactulose hydrogen and [14C]xylose breath tests in patients with ileoanal anastomosis. Int J Colorectal Dis 1991; 6: 208-211 [PMID: 1770288]
33. Ghoshal UC. How to interpret hydrogen breath tests. J Neurogastroenterol Motil 2011; 17: 312-317 [PMID: 21860825 DOI: 10.5056/jnm.2011.17.3.312]
34. Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol 1998; 33: 867-871 [PMID: 9754736 DOI: 10.1080/00365529850171549]
35. Ghoshal UC, Ghoshal U, Ayyagari A, Ranjan P, Krishnani N, Misra A, Aggarwal R, Naik S, Naik SR. Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J Gastroenterol Hepatol 2003; 18: 540-547 [PMID: 12702046 DOI: 10.1046/j.1440-1746.2003.03006.x]
36. Lu CL, Chen CY, Chang FY, Lee SD. Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study. Clin Sci (Lond) 1998; 95: 165-169 [PMID: 9680498 DOI: 10.1042/CS19980040]
37. Sciarretta G, Furno A, Mazzoni M, Garagnani B, Malaguti P. Lactulose hydrogen breath test in orocecal transit assessment. Critical evaluation by means of scintigraphic method. Dig Dis Sci 1994; 39: 1505-1510 [PMID: 8026263 DOI: 10.1007/BF02088056]
38. Rao SS, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, Scott MS, Simren M, Soffer E, Szarka L. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011; 23: 8-23 [PMID: 21138500 DOI: 10.1111/j.1365-2982.2010.01612.x]
39. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011; 60: 334-340 [PMID: 21112950 DOI: 10.1136/gut.2009.205476]
40. Rana SV, Sharma S, Sinha SK, Kaur H, Sikander A, Singh K. Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India. Dig Dis Sci 2009; 54: 132-135 [PMID: 18493854 DOI: 10.1007/s10620-008-0315-x]
41. Dridi B, Henry M, El Khéchine A, Raoult D, Drancourt M. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One 2009; 4: e7063 [PMID: 19759898 DOI: 10.1371/journal.pone.0007063]
42. Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007; 102: 837-841 [PMID: 17397408 DOI: 10.1111/j.1572-0241.2007.01072.x]
43. Lunia MK, Sharma BC, Sachdeva S. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy. Hepatol Int 2013; 7: 268-273 [DOI: 10.1007/s12072-012-9360-9]
44. Resmini E, Parodi A, Savarino V, Greco A, Rebora A, Minuto F, Ferone D. Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients. J Clin Endocrinol Metab 2007; 92: 2119-2124 [PMID: 17405840 DOI: 10.1210/jc.2006-2509]
45. Hamilton I, Worsley BW, Cobden I, Cooke EM, Shoesmith JG, Axon AT. Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth. Gut 1982; 23: 847-853 [PMID: 6749605 DOI: 10.1136/ gut.23.10.847]
46. Corazza GR, Sorge M, Strocchi A, Benati G, Di Sario A, Treggiari EA, Brusco G, Gasbarrini G. Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital J Gastroenterol 1992; 24: 4-9 [PMID: 1486197]
47. Kuwahara T, Ogura Y, Oshima K, Kurokawa K, Ooka T, Hirakawa H, Itoh T, Nakayama-Imaohji H, Ichimura M, Itoh K, Ishifune C, Maekawa Y, Yasutomo K, Hattori M, Hayashi T. The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing. DNA Res 2011; 18: 291-303 [PMID: 21791478 DOI: 10.1093/dnares/dsr022]
48. Beumer RR, de Vries J, Rombouts FM. Campylobacter jejuni non-culturable coccoid cells. Int J Food Microbiol 1992; 15: 153-163 [PMID: 1622752 DOI: 10.1016/0168-1605(92)90144-R]
49. Fromm H, Sarva RP, Ravitch MM, McJunkin B, Farivar S, Amin P. Effects of jejunoileal bypass on the enterohepatic circulation of bile acids, bacterial flora in the upper small intestine, and absorption of vitamin B12. Metabolism 1983; 32: 1133-1141 [PMID: 6645962 DOI: 10.1016/0026-0495(83)90060-4]
50. Yoshida T, McCormick WC, Swell L, Vlahcevic ZR. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism. Gastroenterology 1975; 68: 335-341 [PMID: 1116679]
51. Bjørneklett A, Fausa O, Midtvedt T. Bacterial overgrowth in jejunal and ileal disease. Scand J Gastroenterol 1983; 18: 289-298 [PMID: 6369510 DOI: 10.3109/00365528309181596]
52. Vanner S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut 2008; 57: 1315-1321 [PMID: 18250127 DOI: 10.1136/ gut.2007.133629]
53. Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: implications for future health care. Curr Gastroenterol Rep 2008; 10: 396-403 [PMID: 18627653 DOI: 10.1007/s11894-008-0075-y]
54. Clauw DJ. Fibromyalgia: an overview. Am J Med 2009; 122: S3-S13 [PMID: 19962494 DOI: 10.1016/j.amjmed.2009.09.006]
55. Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004; 63: 450-452 [PMID: 15020342 DOI: 10.1136/ard.2003.011502]
56. Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55: 297-303 [PMID: 16474100 DOI: 10.1136/ gut.2005.075127]
57. Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, Gasbarrini G. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 2007; 25: 237-240 [PMID: 17827947 DOI: 10.1159/000103892]
58. Ghoshal UC, Srivastava D, Verma A, Misra A. Slow transit constipation associated with excess methane production and its improvement following rifaximin therapy: a case report. J Neurogastroenterol Motil 2011; 17: 185-188 [PMID: 21602997 DOI: 10.5056/jnm.2011.17.2.185]
59. Bala L, Ghoshal UC, Ghoshal U, Tripathi P, Misra A, Gowda GA, Khetrapal CL. Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on uppergut aspirate using 1H NMR spectroscopy. Magn Reson Med 2006; 56: 738-744 [PMID: 16972311]
60. Haboubi NY, Lee GS, Montgomery RD. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. Age Ageing 1991; 20: 29-32 [PMID: 2028847 DOI: 10.1093/ageing/20.1.29]
61. Shindo K, Machida M, Koide K, Fukumura M, Yamazaki R. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology 1998; 45: 1643-1650 [PMID: 9840121]
62. Wanitschke R, Ammon HV. Effects of dihydroxy bile acids and hydroxy fatty acids on the absorption of oleic acid in the human jejunum. J Clin Invest 1978; 61: 178-186 [PMID: 338629]
63. Shanab AA, Scully P, Crosbie O, Buckley M, O'Mahony L, Shanahan F, Gazareen S, Murphy E, Quigley EM. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 2011; 56: 1524-1534 [PMID: 21046243 DOI: 10.1007/s10620-010-1447-3]
64. Ghoshal UC, Park H, Gwee KA. Bugs and irritable bowel syndrome: The good, the bad and the ugly. J Gastroenterol Hepatol 2010; 25: 244-251 [PMID: 20074148 DOI: 10.1111/ j.1440-1746.2009.06133.x]
65. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005; 100: 2560-2568 [PMID: 16279914 DOI: 10.1111/j.1572-0241.2005.00230.x]
66. Cherbut C, Aubé AC, Blottière HM, Galmiche JP. Effects of short-chain fatty acids on gastrointestinal motility. Scand J Gastroenterol Suppl 1997; 222: 58-61 [PMID: 9145449]
67. Ramakrishna BS, Roediger WE. Bacterial short chain fatty acids: their role in gastrointestinal disease. Dig Dis 1990; 8: 337-345 [PMID: 2272123 DOI: 10.1159/000171266]
68. Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber JC. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology 1998; 139: 3780-3786 [PMID: 9724030]
69. Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982; 5: 185-194 [PMID: 7121297]
70. Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1231-1238 [PMID: 10811333 DOI: 10.1111/j.1572-0241.2000.02015.x]
71. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70: 443-459 [PMID: 1938669 DOI: 10.1111/j.1365-2672.1991. tb02739.x]
72. Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol 2008; 42. Suppl 3 Pt 1: S123-S125 [PMID: 18806702 DOI: 10.1097/ MCG.0b013e3181574393]
73. Spiller R. Probiotics: an ideal anti-inflammatory treatment for IBS? Gastroenterology 2005; 128: 783-785 [PMID: 15765414 DOI: 10.1053/j.gastro.2005.01.018]
74. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7: 1279-1286 [PMID: 19602448 DOI: 10.1016/j.cgh.2009.06.031]
75. Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol 2006; 52: 89-95 [PMID: 16554709]
76. Di Stefano M, Corazza GR. Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin. Chemotherapy 2005; 51 Suppl 1: 103-109 [PMID: 15855754]
77. Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364: 22-32 [PMID: 21208106 DOI: 10.1056/NEJMoa1004409]
78. Hwang L, Low K, Khoshini R, Melmed G, Sahakian A, Makhani M, Pokkunuri V, Pimentel M. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci 2010; 55: 398-403 [PMID: 19294509 DOI: 10.1007/ s10620-009-0778-4]
79. Low K, Hwang L, Hua J, Zhu A, Morales W, Pimentel M. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. J Clin Gastroenterol 2010; 44: 547-550 [PMID: 19996983 DOI: 10.1097/MCG.0b013e3181c64c90]
80. Bengmark S. Colonic food: pre-and probiotics. Am J Gastroenterol 2000; 95: S5-S7 [PMID: 10634219]
81. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130: S78-S90 [PMID: 16473077]
82. Xiao SD, Zhang DZ, Lu H, Jiang SH, Liu HY, Wang GS, Xu GM, Zhang ZB, Lin GJ, Wang GL. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther 2003; 20: 253-260 [PMID: 14964345]
83. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541-551 [PMID: 15765388]
84. Tsuchiya J, Barreto R, Okura R, Kawakita S, Fesce E, Marotta F. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis 2004; 5: 169-174 [PMID: 15612887]
85. Kim YG, Moon JT, Lee KM, Chon NR, Park H. [The effects of probiotics on symptoms of irritable bowel syndrome]. Korean J Gastroenterol 2006; 47: 413-419 [PMID: 16809947]
86. Park JS, Yu JH, Lim HC, Kim JH, Yoon YH, Park HJ, Lee SI. [Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome]. Korean J Gastroenterol 2010; 56: 242-248 [PMID: 20962560]
87. Mann NS, Limoges-Gonzales M. The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome. Hepatogastroenterology 2009; 56: 718-721 [PMID: 19621689]
88. Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundarò C, Gasbarrini A. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr 2009; 155: 416-420 [PMID: 19535093 DOI: 10.1016/j.jpeds.2009.03.033]
89. Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 21: 1391-1395 [PMID: 15932370 DOI: 10.1111/j.1365-2036.2005.02493.x]
90. Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol 2010; 10: 23 [PMID: 20175924 DOI: 10.1186/1471-230X-10-23]
91. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8: 504-508 [PMID: 20060064 DOI: 10.1016/j.cgh.2009.12.022]
92. Parodi A, Dulbecco P, Savarino E, Giannini EG, Bodini G, Corbo M, Isola L, De Conca S, Marabotto E, Savarino V. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol 2009; 43: 962-966 [PMID: 19525858 DOI: 10.1097/MCG.0b013e3181a099a5]
93. Rana SV, Sinha SK, Sikander A, Bhasin DK, Singh K. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study. Trop Gastroenterol 2008; 29: 23-25 [PMID: 18564663]
94. Majewski M, McCallum RW. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci 2007; 52: 139-142 [PMID: 18217406]
95. Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gasbarrini G, Gasbarrini A. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence casecontrol study in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 1157-1160 [PMID: 16305730 DOI: 10.1111/ j.1365-2036.2005.02690.x]